Cannabis Science is Pharmaceuticals in United States that focus on Cannabis Science Inc business. Founded in 1996. They cover business area such as Cannabis Science Inc, development, phytocannabinoid-base pharmaceutical grade product, critical illness, adhere, scientific methodology, phytocannabinoid-base pharmaceutical product, cannabis-base medicine, psychoactive property, disease, general health maintenance.
1996
( 28 years old in 2024 )
Cannabis Science Inc
-
19800 MacArthur Boulevard
Suite 300
Irvine, CA 92612
United States
Private
Cannabis Science Incdevelopmentphytocannabinoid-base pharmaceutical grade productcritical illnessadherescientific methodologyphytocannabinoid-base pharmaceutical productcannabis-base medicinepsychoactive propertydiseasegeneral health maintenance
* We use standard office opening hours in near Cannabis Science's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cannabis Science is Pharmaceuticals business from United States that founded in 1996 (28 years old in 2024), Cannabis Science business is focusing on Cannabis Science Inc.
Cannabis Science headquarter office and corporate office address is located in 19800 MacArthur Boulevard Suite 300 Irvine, CA 92612 United States.
Cannabis Science was founded in United States.
In 2024, Cannabis Science is currently focus on Cannabis Science Inc sector.
Above is snippet of Google Trends for "Cannabis Science Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cannabis Science, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
